Clinical trials

A Phase I/Ib Trial of the CDK4/6 Antagonist Ribociclib And The HDAC Inhibitor Belinostat In Patients With Metastatic Triple Negative Breast Cancer And Recurrent Ovarian Cancer With Response Prediction By Genomics (CHARGE)

A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer (A021806)

Nasal Biomarker for Lung Cancer Screening

A Phase 2 Multi-Cohort, Open-Label, Multi-Center Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin (RC48-ADC) Alone and in Combination with Pembrolizumab in Subjects with Locally-Advanced Unresectable or Metastatic Urothelial Carcinoma That Expresses HER2 (Seagen RC48G001)

A Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients with Methylated MGMT Promoter Glioblastoma (NRG-BN011)

Open-label study of Androgen Receptor Inhibition with Darolutamide plus Androgen Deprivation Therapy (ADT) Versus ADT in men with Metastatic Hormone-Sensitive Prostate Cancer Using an External Control Arm (Bayer 21516 ARASEC)

S1914 - A Randomized Phase III Trial Of Induction/Consolidation Atezolizumab + Sbrt Versus Sbrt Alone In High Risk, Early Stage NSCLC

ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study (Chimerix ACTION)

Prospective Research-based Observational Study of Poteligeo® Experience in the Real World in Adult Patients with Mycosis Fungoides and Sézary Syndrome (PROSPER)

LOXO-RAS-20001: A Phase 1/2 Study of LY3537982 in Patients with KRAS G12C-Mutant Advanced Solid Tumors